Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.
European journal of haematology(2023)
摘要
ClinicalTrials.gov NCT01356680.
更多查看译文
关键词
FDG PET, Hodgkin lymphoma, metabolic tumor volume, response prediction
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要